Ignite Creation Date:
2024-05-06 @ 4:14 PM
Last Modification Date:
2024-10-26 @ 2:06 PM
Study NCT ID:
NCT04922151
Status:
UNKNOWN
Last Update Posted:
2021-06-10
First Post:
2021-06-04
Brief Title:
601 Versus Ranibizumab in Patients With Pathological Myopic Choroidal Neovascularization pmCNV
Sponsor:
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
Organization:
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Pathological Myopic Choroidal Neovascularization |
Keywords:
| Name | View |
|---|---|
| VEGF pmCNV antibody | View |